Delivery Order SPE2DB20D3101-SPE2DB23FRBG0
- Not listed
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,365.33 and a performance period ending on April 7, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,682.40 for 4566529191 EXFORGE 5-320 MG TABLET 30S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,743.68 firm fixed-price contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $1,740.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract covers the delivery of the pharmaceutical product "EXFORGE 5-320 MG TABLET 30S" to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,828.55 firm fixed-price delivery order is for the supply of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication. The award has an ultimate completion date of August 1, 2022 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $5,057.78, is for the delivery of EXFORGE 10-160 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,165.48, is a firm fixed-price delivery order for the supply of EXFORGE 5-160 MG TABLET 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award for $1,882.41 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, and has an ultimate completion date of September 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
- This is a $1,155.95 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the provision of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of March 14, 2024 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating it was competitively bid. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,297.14 delivery order contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) agreement with a completion date of January 25, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRBG0Delivery Order
This award is a Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the pharmaceutical product EXFORGE 5-160 MG TABLET 30S. The award, valued at $1,592.28, has a firm fixed price and an ultimate completion date of January 30, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition. The award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/27/23 |